AfriKADIA is a consortium created to find improved treatments and diagnostic tools for visceral leishmaniasis in eastern Africa.
Over the past 12 years, AfriKADIA Consortium partners have conducted innovative visceral leishmaniasis trials in the eastern Africa region. Many of these were joint efforts.
The consortium is comprised of: three universities and one research institution from eastern Africa with many years of experience in tropical disease research; four European research institutions with a track record in field-based research; and two not-for-profit product development partnerships specialising in R&D for neglected diseases.
The AfriKADIA Consortium is funded by the European & Developing Countries Clinical Trials Partnership (EDCTP). This project is part of the EDCTP2 programme which is supported by the European Union under Horizon 2020, its Framework Programme for Research and Innovation.